Brandywine Global Investment Management, LLC Genmab A/S Transaction History
Brandywine Global Investment Management, LLC
- $13.4 Billion
- Q4 2024
A detailed history of Brandywine Global Investment Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 1,619,764 shares of GMAB stock, worth $33.9 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,619,764Holding current value
$33.9 Million% of portfolio
0.25%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
229Shares Held
50.9MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY14.9MShares$312 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$106 Million0.0% of portfolio
-
Orbis Allan Gray LTD Hamilton, D02.82MShares$58.9 Million0.4% of portfolio
-
Capital International Investors Los Angeles, CA2.57MShares$53.8 Million0.01% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.24MShares$46.9 Million0.33% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $13.8B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...